The International Society for Sexual Medicine defined premature ejaculation as ” ejaculation that always or nearly always occurs prior to or within about one minute. ” Covered in this Report This report covers the present scenario and the growth prospects of the Global Premature Ejaculation market for the period 2013-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of premature ejaculation that are available in the market.
Our writers will create one from scratch for
View our full TCO here Key Regions MEME OPAC Americas Key Vendors Absorption Pharmaceuticals LLC Furies Pharmaceuticals Inc. Minibus Pharmaceuticals Inc. Plethora Solutions Ltd. Other Prominent Vendors Brayer Dong-A Pharmaceutical Dong-A SST Eli Lilly McClure End Silhouetting Mediums Marine Unrevealing Pfizer Cushioning SOMY Vesture Writ Key Market Driver Presence of Unmet Need For a full, detailed list, view our report. Key Market Challenge Unknown Etiology Key Market Trend
Increase in Awareness of Premature Ejaculation Key Questions Answered in this Report What will the market size be in 2018 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? For more insights, view our Global Premature Ejaculation Market 2014-2018 report.